Related Guidance Notes
GNL 41: Preliminary injunctive relief in patent disputes
GNL 40: Flexible remedies in life science patent disputes
GNL 33: Patents in the company lifecycle: M&A and joint ventures
GNL 34: Patents in the company lifecycle: IPO and divestment
GNL 31: Open innovation
GNL 32: The importance of IP due diligence
GNL 30: Regulating life sciences products in the transition period
GNL 29: Biosimilars and naming duplicates
GNL 27: IPEC Cost effective and quick procedure for IP disputes
GNL 25: Data and market exclusivity: additional protections
GNL 24: Data and market exclusivity: what it is and how long it lasts
GNL 20: Paediatric extensions
GNL 7: Infringement – Supplementary Protection Certificates
GNL 6: Introduction to Patent Infringement
